PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE ACETATE

The embodiments of present invention provide processes and an intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide hemisuccinate, and formulations and product forms made by these processes. The embodiments of the present invention f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FRANK, SCOTT ALAN, VAID, RADHE KRISHAN, ROTHHAAR, ROGER RYAN, KERR, MARK STEVEN, ABURUB, AKTHAM, COATES, DAVID ANDREW
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FRANK, SCOTT ALAN
VAID, RADHE KRISHAN
ROTHHAAR, ROGER RYAN
KERR, MARK STEVEN
ABURUB, AKTHAM
COATES, DAVID ANDREW
description The embodiments of present invention provide processes and an intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide hemisuccinate, and formulations and product forms made by these processes. The embodiments of the present invention further provide for the preparation of lasmiditan acetate, 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide acetate salt, and/or pharmaceutical compositions thereof, and/or uses of lasmiditan acetate and formulations thereof in subcutaneous drug delivery. Les modes de réalisation de la présente invention concernent des procédés et un intermédiaire de préparation à grande échelle d'hémisuccinate de 2,4,6-trifluoro-N-[6-(1-méthylpipéridine-4-carbonyl)-2-pyridyl]benzamide, et des formulations et formes de produits fabriquées par ces procédés. Les modes de réalisation de la présente invention concernent également la préparation d'acétate de lasmiditan, d'un sel d'acétate de 2,4,6-trifluoro-N-[6-(1-méthylpipéridine-4-carbonyl)-2-pyridyl]benzamide, et/ou leurs compositions pharmaceutiques, et/ou des utilisations de l'acétate de lasmiditan et des formulations de ce dernier dans l'administration sous-cutanée de médicament.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3146129C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3146129C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3146129C3</originalsourceid><addsrcrecordid>eNq1zkFLw0AQBeCKeBDtb3COCplD0hDwOJ1MzMBmd5ndHtIipch6Ei3U_4-lePfk6cHjwfdur66jBZaUJAH5HtRnsUl6pSwwBIM8CjiyF8HE5ASiSSSjrMFDGKCp2qrDbDq4TbCAHncdPtY4SR5nh1GjmPbqBVtksnXws3vCOF9KbHB2r7gWv6VJe4FRJk0bZvVnvroc-lePWPJZul_cvB8-TmX5m3eLh0Eyj1iOX_tyOh7eymf53jOt6rarm2de_b34AXL1XMQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE ACETATE</title><source>esp@cenet</source><creator>FRANK, SCOTT ALAN ; VAID, RADHE KRISHAN ; ROTHHAAR, ROGER RYAN ; KERR, MARK STEVEN ; ABURUB, AKTHAM ; COATES, DAVID ANDREW</creator><creatorcontrib>FRANK, SCOTT ALAN ; VAID, RADHE KRISHAN ; ROTHHAAR, ROGER RYAN ; KERR, MARK STEVEN ; ABURUB, AKTHAM ; COATES, DAVID ANDREW</creatorcontrib><description>The embodiments of present invention provide processes and an intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide hemisuccinate, and formulations and product forms made by these processes. The embodiments of the present invention further provide for the preparation of lasmiditan acetate, 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide acetate salt, and/or pharmaceutical compositions thereof, and/or uses of lasmiditan acetate and formulations thereof in subcutaneous drug delivery. Les modes de réalisation de la présente invention concernent des procédés et un intermédiaire de préparation à grande échelle d'hémisuccinate de 2,4,6-trifluoro-N-[6-(1-méthylpipéridine-4-carbonyl)-2-pyridyl]benzamide, et des formulations et formes de produits fabriquées par ces procédés. Les modes de réalisation de la présente invention concernent également la préparation d'acétate de lasmiditan, d'un sel d'acétate de 2,4,6-trifluoro-N-[6-(1-méthylpipéridine-4-carbonyl)-2-pyridyl]benzamide, et/ou leurs compositions pharmaceutiques, et/ou des utilisations de l'acétate de lasmiditan et des formulations de ce dernier dans l'administration sous-cutanée de médicament.</description><language>eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231212&amp;DB=EPODOC&amp;CC=CA&amp;NR=3146129C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231212&amp;DB=EPODOC&amp;CC=CA&amp;NR=3146129C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FRANK, SCOTT ALAN</creatorcontrib><creatorcontrib>VAID, RADHE KRISHAN</creatorcontrib><creatorcontrib>ROTHHAAR, ROGER RYAN</creatorcontrib><creatorcontrib>KERR, MARK STEVEN</creatorcontrib><creatorcontrib>ABURUB, AKTHAM</creatorcontrib><creatorcontrib>COATES, DAVID ANDREW</creatorcontrib><title>PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE ACETATE</title><description>The embodiments of present invention provide processes and an intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide hemisuccinate, and formulations and product forms made by these processes. The embodiments of the present invention further provide for the preparation of lasmiditan acetate, 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide acetate salt, and/or pharmaceutical compositions thereof, and/or uses of lasmiditan acetate and formulations thereof in subcutaneous drug delivery. Les modes de réalisation de la présente invention concernent des procédés et un intermédiaire de préparation à grande échelle d'hémisuccinate de 2,4,6-trifluoro-N-[6-(1-méthylpipéridine-4-carbonyl)-2-pyridyl]benzamide, et des formulations et formes de produits fabriquées par ces procédés. Les modes de réalisation de la présente invention concernent également la préparation d'acétate de lasmiditan, d'un sel d'acétate de 2,4,6-trifluoro-N-[6-(1-méthylpipéridine-4-carbonyl)-2-pyridyl]benzamide, et/ou leurs compositions pharmaceutiques, et/ou des utilisations de l'acétate de lasmiditan et des formulations de ce dernier dans l'administration sous-cutanée de médicament.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNq1zkFLw0AQBeCKeBDtb3COCplD0hDwOJ1MzMBmd5ndHtIipch6Ei3U_4-lePfk6cHjwfdur66jBZaUJAH5HtRnsUl6pSwwBIM8CjiyF8HE5ASiSSSjrMFDGKCp2qrDbDq4TbCAHncdPtY4SR5nh1GjmPbqBVtksnXws3vCOF9KbHB2r7gWv6VJe4FRJk0bZvVnvroc-lePWPJZul_cvB8-TmX5m3eLh0Eyj1iOX_tyOh7eymf53jOt6rarm2de_b34AXL1XMQ</recordid><startdate>20231212</startdate><enddate>20231212</enddate><creator>FRANK, SCOTT ALAN</creator><creator>VAID, RADHE KRISHAN</creator><creator>ROTHHAAR, ROGER RYAN</creator><creator>KERR, MARK STEVEN</creator><creator>ABURUB, AKTHAM</creator><creator>COATES, DAVID ANDREW</creator><scope>EVB</scope></search><sort><creationdate>20231212</creationdate><title>PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE ACETATE</title><author>FRANK, SCOTT ALAN ; VAID, RADHE KRISHAN ; ROTHHAAR, ROGER RYAN ; KERR, MARK STEVEN ; ABURUB, AKTHAM ; COATES, DAVID ANDREW</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3146129C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>FRANK, SCOTT ALAN</creatorcontrib><creatorcontrib>VAID, RADHE KRISHAN</creatorcontrib><creatorcontrib>ROTHHAAR, ROGER RYAN</creatorcontrib><creatorcontrib>KERR, MARK STEVEN</creatorcontrib><creatorcontrib>ABURUB, AKTHAM</creatorcontrib><creatorcontrib>COATES, DAVID ANDREW</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FRANK, SCOTT ALAN</au><au>VAID, RADHE KRISHAN</au><au>ROTHHAAR, ROGER RYAN</au><au>KERR, MARK STEVEN</au><au>ABURUB, AKTHAM</au><au>COATES, DAVID ANDREW</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE ACETATE</title><date>2023-12-12</date><risdate>2023</risdate><abstract>The embodiments of present invention provide processes and an intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide hemisuccinate, and formulations and product forms made by these processes. The embodiments of the present invention further provide for the preparation of lasmiditan acetate, 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide acetate salt, and/or pharmaceutical compositions thereof, and/or uses of lasmiditan acetate and formulations thereof in subcutaneous drug delivery. Les modes de réalisation de la présente invention concernent des procédés et un intermédiaire de préparation à grande échelle d'hémisuccinate de 2,4,6-trifluoro-N-[6-(1-méthylpipéridine-4-carbonyl)-2-pyridyl]benzamide, et des formulations et formes de produits fabriquées par ces procédés. Les modes de réalisation de la présente invention concernent également la préparation d'acétate de lasmiditan, d'un sel d'acétate de 2,4,6-trifluoro-N-[6-(1-méthylpipéridine-4-carbonyl)-2-pyridyl]benzamide, et/ou leurs compositions pharmaceutiques, et/ou des utilisations de l'acétate de lasmiditan et des formulations de ce dernier dans l'administration sous-cutanée de médicament.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3146129C
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE ACETATE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T14%3A02%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FRANK,%20SCOTT%20ALAN&rft.date=2023-12-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3146129C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true